Reports for JAMP PHARMA CORPORATION
Company Name
JAMP PHARMA CORPORATION
Totals |
||
Shortage reports |
527 |
|
| Actual shortage: | 137 (26%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (0%) | |
| Resolved: | 389 (74%) | |
Discontinuation Reports |
14 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 14 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
125 (23%) |
|
Overdue reports |
81 (59%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| JAMP RABEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2023-09-11 | 2024-04-29 | 204044 |
| JAMP RABEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2023-09-11 | 2024-04-29 | 204047 |
| VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Actual shortage | 2023-09-26 | 2024-03-30 | 205261 |
| JAMP-RISPERIDONE | 1MG | SOLUTION | Actual shortage | 2023-10-18 | 2023-11-15 | 207292 |
| JAMP-MOXIFLOXACIN | 0.5% | SOLUTION | Actual shortage | 2023-10-18 | 2024-03-19 | 207295 |
| JAMP-URSODIOL | 250MG | TABLET | Actual shortage | 2023-10-18 | 2024-03-12 | 207298 |
| JAMP-URSODIOL | 250MG | TABLET | Actual shortage | 2023-10-18 | 2024-03-12 | 207301 |
| JAMP LAMIVUDINE / ZIDOVUDINE | 150MG 300MG | TABLET | Resolved | 2023-10-18 | 2024-05-10 | 207304 |
| JAMP GEFITINIB | 250MG | TABLET | Resolved | 2023-10-18 | 2024-02-05 | 207314 |
| CETIRIZINE EXTRA STRENGTH | 10MG | TABLET CAPSULE | Resolved | 2023-10-18 | 2024-01-04 | 207328 |
| JAMP-EFAVIRENZ | 600MG | TABLET | Actual shortage | 2023-10-18 | 2024-02-06 | 207333 |
| JAMP ELETRIPTAN | 20MG | TABLET | Resolved | 2023-10-18 | 2024-04-29 | 207338 |
| JAMP ELETRIPTAN | 40MG | TABLET | Resolved | 2023-10-18 | 2024-04-29 | 207344 |
| JAMP CALCIUM POLYSTYRENE SULFONATE | 999MG | POWDER FOR SUSPENSION | Actual shortage | 2023-10-18 | 2024-03-30 | 207347 |
| JAMP CANDESARTAN-HCT | 16MG 12.5MG | TABLET | Resolved | 2023-11-28 | 2024-05-25 | 211765 |
| JAMP CANDESARTAN-HCT | 12.5MG 32MG | TABLET | Resolved | 2023-11-28 | 2024-05-25 | 211768 |
| JAMP CANDESARTAN-HCT | 12.5MG 32MG | TABLET | Resolved | 2023-11-28 | 2024-05-25 | 211771 |
| JAMP CANDESARTAN-HCT | 25MG 32MG | TABLET | Actual shortage | 2023-11-28 | 2024-04-17 | 211774 |
| JAMP CANDESARTAN-HCT | 25MG 32MG | TABLET | Actual shortage | 2023-11-28 | 2024-04-17 | 211777 |
| JAMP-CHOLESTYRAMINE | 4G | POWDER FOR SUSPENSION | Actual shortage | 2023-11-28 | 2024-02-06 | 211780 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| JAMP-ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113293 |
| JAMP-ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113296 |
| JAMP-ALPRAZOLAM | 0.5MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113299 |
| JAMP-ALPRAZOLAM | 0.5MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113302 |
| JAMP-ALPRAZOLAM | 1MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113305 |
| JAMP-ALPRAZOLAM | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113308 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168981 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168984 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168987 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168990 |
| JAMP-RIZATRIPTAN IR | 10MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168995 |
| JAMP-RIZATRIPTAN IR | 10MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168998 |
| JAMP-SILDENAFIL | 25.0MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 169003 |
| JAMP-SILDENAFIL | 50.0MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 169006 |
Showing 1 to 14 of 14